Advertisement

Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px
Document › Details

GenSight Biologics S.A.. (10/22/20). "Press Release: GenSight Biologics Successfully Raises €25 Million in an Oversubscribed Private Placement With US and European Institutional Investors". Paris.

Organisations Organisation GenSight Biologics S.A. (Euronext: SIGHT)
  Organisation 2 Arix Bioscience plc (LSE: ARIX)
  Today Arix Bioscience (Group)
  Group Arix Bioscience (Group)
Products Product Lumevoq®
  Product 2 investment banking
Index term Index term GenSight Biologics–SEVERAL: investment, 202010 private placement €25m led by Arix Bioscience + Invus + Sofinnova Partners
Persons Person Gilly, Bernard (GenSight Biologics 201304 CEO + Co-founder before Fovea + Sofinnova Partners + Transgene)
  Person 2 Gidoin, Thomas (GenSight Biologics 201507 CFO)
     


   
Record changed: 2020-12-09

Advertisement

Picture ConsulTech GmbH RnD Credit Germany 650x80px

More documents for GenSight Biologics S.A. (Euronext: SIGHT)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81




» top